Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UF scientist finds unexpected link between cat and human AIDS viruses

09.09.2005


Emerging relationships between the two viruses could one day lead to a vaccine for human AIDS

A University of Florida researcher has discovered an unexpected link between the viruses that cause feline and human AIDS: Cats vaccinated with an experimental strain of the human AIDS virus appear to be at least as well-protected against the feline version of the disease as those immunized with the vaccine currently used by veterinarians.

The surprise finding may mean cats with feline immunodeficiency virus, also known as FIV or feline AIDS, could eventually be treated even more effectively using some form of the experimental human vaccine.



Researcher Janet Yamamoto, a professor at UF’s College of Veterinary Medicine, also theorizes that these emerging relationships between the two viruses could one day lead to a vaccine for human AIDS.

Results from Yamamoto’s research can be previewed in today’s (Sept. 8) online issue of the journal AIDS.

FIV is a natural infection of domestic cats that results in an immunodeficiency syndrome resembling HIV infection in humans. Since its discovery in 1987, FIV infection of cats has been used in vaccine studies as a small-animal model of human AIDS.

"We were the first to demonstrate that you can make an effective vaccine against a virus in the AIDS family of viruses," said Yamamoto, a co-discoverer of FIV.

Yamamoto holds the patent on the only approved vaccine available through veterinarians to protect cats against FIV. Her most recent studies have attempted to improve the efficacy of that vaccine by using strains of FIV found in cats in which the disease had not progressed for some reason over several years.

To determine the extent to which the human and feline AIDS viruses react to each other, and any implications that might exist for vaccine efficacy, Yamamoto began experimenting with long-term, nonprogressive strains of FIV that led to the current commercial vaccine. Now she is working on an HIV vaccine consisting of HIV virus from long-term, nonprogressing individuals.

"We purposely made vaccines with strains that weren’t virile," Yamamoto said. "We found that whenever we tried using less virulent strains of virus, we were able to make a better vaccine."

Yamamoto’s team was also surprised to discover that a core protein found in HIV also effectively protects cats against FIV.

"So what does this mean to human AIDS research? The viruses HIV and FIV are from the same viral family," Yamamoto said. "For that reason, the amino acids that make up the proteins in both viruses share some common regions. There appear to be regions of HIV, or variations of the core protein we used in our studies, that may provide protection in vaccine form against HIV."

Some compounds made from separate virus strains have been successfully used in vaccines against viruses from the same subfamily, such as smallpox in humans, which is made from cowpox virus, and human measles vaccines for canine distemper in puppies.

"Therefore, protective vaccines based on cross-reactive regions of AIDS viruses can provide broad immunity, and may be useful against viruses that are currently evolving in a new host, such as HIV infection of humans," Yamamoto said.

Alan L. Landay, a professor of immunology and microbiology and associate department chairman at Rush University Medical Center in Chicago called Yamamoto’s findings "very exciting."

"This raises a potential whole new area for research in the field of vaccines that with the current approaches haven’t yielded any success to date," said Landay, whose research team is working to develop novel immune strategies to treat HIV infection. "We need to explore all the potential options available to us for developing an HIV vaccine."

Sarah Carey | EurekAlert!
Further information:
http://www.vetmed.ufl.edu

More articles from Health and Medicine:

nachricht Using fragment-based approaches to discover new antibiotics
21.06.2018 | SLAS (Society for Laboratory Automation and Screening)

nachricht Scientists learn more about how gene linked to autism affects brain
19.06.2018 | Cincinnati Children's Hospital Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Graphene assembled film shows higher thermal conductivity than graphite film

22.06.2018 | Materials Sciences

Fast rising bedrock below West Antarctica reveals an extremely fluid Earth mantle

22.06.2018 | Earth Sciences

Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View

22.06.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>